AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies
Resource Type
Abstract
Authors
Nath, Rajneesh ; Seropian, Stuart ; Choe, Hannah ; Litzow, Mark R. ; Abboud, Camille ; Koshy, Nebu ; Stiff, Patrick J. ; Tomlinson, Benjamin ; Abhyankar, Sunil ; Foran, James M. ; Hari, Parameswaran ; Chen, George L. ; Al-Kadhimi, Zaid S. ; Kebriaei, Partow ; Sabloff, Mitchell ; Orozco, Johnnie J. ; Jamieson, Katarzyna ; Magalhaes-Silverman, Margarida ; Van Besien, Koen ; Schuster, Michael ; Law, Arjun ; Abedin, Sameem ; Larkin, Karilyn ; Rowley, Scott ; Munshi, Pashna ; Cook, Rachel ; Mayer, Sebastian ; Levy, Moshe Yair ; Lazarus, Hillard M. ; Sandmaier, Brenda M. ; Reddy, Vijay ; Spross, Jennifer ; McNamara, Kathleen ; Haeuber, Elaina ; Vusirikala, Madhuri ; Nahar, Akash ; Pagel, John M. ; Giralt, Sergio A. ; Desai, Avinash ; Gyurkocza, Boglarka
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S309-S310
Subject
Language
ISSN
2152-2650